Democrats have introduced a bill that would allow anyone over age 50 to buy into Medicare; an FDA advisory panel has endorsed a ketamine-like depression drug; and the EPA is set to limit the amount of manmade chemicals allowed in drinking water.
On Wednesday, House and Senate Democrats introduced legislation that would allow anyone over age 50 to buy into Medicare. According to POLITICO, the bill sponsors said that the plan will pay for itself with the premiums from new enrollees and more of the money collected would pay for patient care because of “the relative lack of overhead and profit requirements in Medicare compared to the private insurance market.”
An FDA advisory panel has endorsed the experimental medication esketamine for depression. Determining that the benefits outweigh the risks, the panel voted 15-2 in favor of the ketamine-like drug. If the drug, manufactured by Johnson & Johnson, is approved, it would be the first major depression treatment approved in decades, according to STAT News. Some experts have expressed concern that the drug has a high potential for abuse because ketamine is often abused.
The EPA is expected to announce today that it will limit how much toxic chemicals from cookware and carpeting are allowed in drinking water, reported Reuters. The group of chemicals, known as PFAS, have been linked to cancer, liver and thyroid damage, and other health effects. HHS’ Agency for Toxic Substances and Disease Registry said the risk level for exposure to these chemicals should be at least 7 to 10 times lower than the threshold currently recommended by the EPA.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Health Equity & Access Weekly Roundup: November 2, 2024
November 2nd 2024This week’s Center on Health Equity & Access highlights emphasize the role of social determinants of health in policy-making and underscore the importance of addressing rising costs and challenges employers face.
Read More